Standard Operating Procedure for Review of Container Closure and Packaging Data in Dossiers
| Department | Regulatory Affairs |
| SOP No. | RA/2026/719 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 14/04/2026 |
| Effective Date | 14/04/2026 |
| Review Date | 14/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines the systematic process for reviewing container closure and packaging data submitted within regulatory dossiers to ensure accuracy, compliance with regulatory requirements, and adequacy of information. This SOP supports the control objective of maintaining high-quality, consistent documentation that facilitates regulatory submissions, approvals, and ongoing compliance with global good manufacturing practice (GMP) and regulatory standards.
Scope
This SOP applies to the Regulatory Affairs department responsible for the review of container closure and packaging system data included in regulatory dossiers for pharmaceuticals. It covers all dosage forms, packaging components, labeling information, and related documentation submitted for marketing authorization or post-approval changes. Activities outside dossier document review such as manufacturing, quality control testing, or physical inspection of packaging materials are excluded.
Responsibilities
– Regulatory Affairs Officers: Execute dossier data review according to this SOP.
– Regulatory Affairs Supervisors: Oversee review processes and ensure compliance.
– Quality Assurance: Verify completeness and accuracy of documentation.
– Document Control Personnel: Manage controlled issuance and archiving of SOPs and associated records.
– Regulatory Affairs Manager: Ensure proper training and implementation of this SOP.
Accountability
The Regulatory Affairs Manager holds accountability for the effective implementation, compliance monitoring, timely review, escalation of issues, and periodic evaluation of the SOP’s effectiveness within the department.
Procedure
1. Preparation and Prerequisites:
a) Access the regulatory dossier containing container closure and packaging data.
b) Ensure all prerequisite training in document review, regulatory requirements, and relevant SOPs are completed.
c) Confirm availability of current regulatory guidelines and internal specifications related to packaging.
2. Initial Document Verification:
a) Verify completeness of the container closure and packaging section within the dossier.
b) Confirm that all required documents such as specifications, drawings, certificates of analysis, and stability data are included.
c) Check for the correct version and currency of documents aligned with submission timelines.
3. Detailed Review:
a) Review technical details including material composition, compatibility with drug product, and closure integrity data.
b) Evaluate packaging component descriptions, dimensions, tolerances, and compliance with pharmacopeial or regulatory standards.
c) Assess labeling artwork and printing details for regulatory compliance and accuracy.
d) Analyze data on container closure system performance including data on leachables, extractables, and sterilization methods if applicable.
4. Cross-Functional Verification:
a) Coordinate with Quality Assurance and Quality Control to confirm alignment with internal specifications.
b) Consult with manufacturing or engineering teams if technical clarifications are required.
c) Document any discrepancies, deviations, or missing information and raise queries through formal communication.
5. Decision and Documentation:
a) Based on review findings, recommend acceptance, conditional acceptance requiring corrective actions, or rejection of dossier data.
b) Document the review outcome and justifications clearly in a review report or checklist.
c) Obtain requisite approvals from supervisory and QA personnel before finalizing the dossier submission package.
d) Ensure all comments, clarifications, and responses are archived as part of the submission record.
6. Record Retention and Closure:
a) File all review records, reports, correspondences, and approvals in controlled document repositories.
b) Maintain records as per regulatory and internal retention timelines.
c) Close the review process formally by updating the SOP compliance and training logs as necessary.
7. Handling Deviations:
a) Any non-conformities observed during review shall be documented and escalated immediately.
b) Follow internal deviation management procedures to resolve issues before dossier submission.
c) Ensure corrective and preventive actions (CAPA) are implemented and verified.
Strict adherence to this procedure ensures the review of container closure and packaging data is thorough, defensible, and aligned with regulatory expectations, facilitating timely dossier approvals and ongoing compliance.
Abbreviations
– GMP: Good Manufacturing Practice
– SOP: Standard Operating Procedure
– QA: Quality Assurance
– QC: Quality Control
– CAPA: Corrective and Preventive Actions
– CMC: Chemistry, Manufacturing, and Controls
Documents
The following documents are required to support the review process for container closure and packaging data in dossiers:
- Container Closure and Packaging Data Review Checklist (Annexure-1)
- Dossier Packaging Component Specification Template (Annexure-2)
- Packaging Review Report Form (Annexure-3)
References
– ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
– FDA Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics
– EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
– Internal Quality Management System Documentation
– Pharmacopeial Standards (USP, EP) relevant to packaging materials
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Container Closure and Packaging Data Review Checklist
Purpose: To provide a structured list of key review points to ensure completeness and compliance of container closure and packaging data in dossiers.
| Review Item | Compliant (Yes/No) | Comments |
|---|---|---|
| Complete packaging specification included | Yes | – |
| Material composition details verified | Yes | Material compliant with pharmacopeia |
| Closure integrity data available | No | Data to be provided before submission |
| Labeling artwork reviewed | Yes | Meets regulatory requirements |
| Certificates of Analysis attached | Yes | All batches covered |
Annexure-2: Dossier Packaging Component Specification Template
Purpose: To capture detailed specifications of packaging components for inclusion in regulatory dossiers.
| Field | Details |
|---|---|
| Component Name | Amber Glass Vial |
| Material Type | Borosilicate Glass |
| Dimensions | 20 mm diameter x 50 mm height |
| Closure Type | Aluminum Crimp Cap with Rubber Stopper |
| Specifications Reference | Internal Spec No. PKG-GLS-2026-001 |
| Certificate of Analysis | Attached, Batch #20260401 |
| Approval Status | Approved |
Annexure-3: Packaging Review Report Form
Purpose: To document the comprehensive review results and decisions related to container closure and packaging data within a regulatory dossier.
| Field | Entry |
|---|---|
| Dossier No. | RA-2026-1234 |
| Reviewed By | Regulatory Affairs Officer |
| Date of Review | 10/04/2026 |
| Review Findings Summary | Packaging data largely compliant; closure integrity data pending submission. |
| Actions Required | Submit closure integrity validation data before dossier finalization. |
| Reviewer Signature | |
| Approval Signature |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 14/04/2026 | 1.0 | Initial issue | New SOP creation |